摘要
新一轮的医疗改革已经开始,这对仁和药业的未来发展或多或少产生一定影响。众所周知未来可持续性决定公司的未来盛衰,本文从财务角度考察了内部和外部因素对公司可持续发展增长的影响以及对仁和药业可持续增长能力做出评估,分析并对比仁和药业的流动性、盈利能力和研发创新三方面来探究仁和药业的未来可持续性,最后得出结论。
A new round of medical reform has begun,which has more or less affected the future development of Renhe Pharmacy.As is known to all,the future sustainability decides the rise and fall of the company in the future.This paper studies the internal and external factors’impact on sustainable development of the company growth and the evaluation of Renhe Pharmacy sustainable growth ability from the perspective of finance,and made analysis and contrast in three aspects of Renhe Pharmacy,which are liquidity,profitability and development innovation to explore the kernel and the future of the pharmaceutical industry sustainability.Relevant comments,suggestions and conclusions are given in this paper.
出处
《金融》
2019年第5期477-486,共10页
Finance